Sugen's strategy: a signal for P&U purchase.
Glaser
V
V
D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D001709:Biotechnology; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D005060:Europe; D006801:Humans; D007449:Investments; D017008:Negotiating; D011565:Psoriasis / Q000188:drug therapy; D014481:United States
D000970:Antineoplastic Agents